Here, we show that meningeal cell-induced SERPINA3 expression at the tumor/stroma interface promotes the amplification of PI3K/AKT signaling and the reactivation of ERK in the tumor cells, thereby overcoming BRAF/MEK inhibition. Here, AKT1 is linked to neoplasm.